- World rank, all time
- #21,807 of 34,923
- Rank in United States
- #4,529 of 7,310
- Research works
- 215 ▲ 4% vs 2018-21
- Citations
- 3.6k 16.5 per fractional work
- Top-10% rate
- 8.4% all institutions 10.0%
- vs its own fields
- 0.94× 1.00× is exactly expected
- Open access
- 46% world 40%
- International
- 28% world 18%
Which fields of science does ProterixBio (United States) work in?
In 2022-now, 51% of research at ProterixBio (United States) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (24%), Engineering (5%). It does 3.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 23 fields, with their numbers
- Life Sciences3450.6%
- Health Sciences1624.7%
- Medicine1624.0%
- Dentistry00.3%
- Health Professions00.2%
- Nursing00.2%
- Physical Sciences1015.1%
- Engineering45.3%
- Environmental Science23.7%
- Computer Science12.1%
- Materials Science11.3%
- Earth and Planetary Sciences10.9%
- Chemistry10.8%
- Physics and Astronomy00.6%
- Chemical Engineering00.3%
- Energy00.1%
- Social Sciences69.7%
What does ProterixBio (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 12.2× the share of its output that it takes of world research.
- Molecular BiologySubfield · 24.4 works12×
- Biochemistry, Genetics and Molecular BiologyField · 27.7 works7.8×
- Life SciencesDomain · 33.6 works3.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.8×. Every wedge is a field page.
All 23 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology7.83×28 works
- Immunology and Microbiology2.81×2 works
- Neuroscience1.95×2 works
- Pharmacology, Toxicology and Pharmaceutics1.66×0 works
- Medicine1.25×16 works
- Business, Management and Accounting0.90×2 works
- Environmental Science0.75×2 works
- Chemical Engineering0.72×0 works
- Economics, Econometrics and Finance0.65×1 works
- Dentistry0.62×0 works
- Earth and Planetary Sciences0.56×1 works
- Chemistry0.54×1 works
- Agricultural and Biological Sciences0.48×2 works
- Arts and Humanities0.40×1 works
- Engineering0.36×4 works
- Materials Science0.36×1 works
- Nursing0.34×0 works
- Social Sciences0.32×3 works
- Physics and Astronomy0.29×0 works
- Computer Science0.27×1 works
- Energy0.09×0 works
- Health Professions0.07×0 works
- Psychology0.07×0 works
- Biochemistry, Genetics and Molecular Biology 7.8×
- Immunology and Microbiology 2.8×
- Neuroscience 1.9×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Medicine 1.2×
- Business, Management and Accounting 0.9×
- Environmental Science 0.8×
- Chemical Engineering 0.7×
- Economics, Econometrics and Finance 0.7×
- Dentistry 0.6×
- Earth and Planetary Sciences 0.6×
- Chemistry 0.5×
- Agricultural and Biological Sciences 0.5×
- Arts and Humanities 0.4×
- Engineering 0.4×
- Materials Science 0.4×
- Nursing 0.3×
- Social Sciences 0.3×
- Physics and Astronomy 0.3×
- Computer Science 0.3×
- Energy 0.1×
- Health Professions 0.1×
- Psychology 0.1×
Who are the top researchers at ProterixBio (United States)?
Ranked on the quality score, John K. Yoon and Luigi Barbarossa lead among researchers whose main affiliation is ProterixBio (United States).
- 1
John K. Yoon
United States · #3,001,453 worldwide 297 citations · 15 works
- 2
Luigi Barbarossa
United States · #3,021,124 worldwide 534 citations · 17 works
Which keywords describe research at ProterixBio (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Gene Regulation, Cancer, Innate Immunity, Alternative Splicing, RNA-Binding Proteins, Chromatin, Ribosome and Translation.
- Repair
- DNA Damage
- Myofibroblast
- G-Quadruplexes
- Therapeutic Targets
- Interstitial Lung Disease
- Fibrosis
- Genomic Instability
- Precision Medicine
- Genome Engineering
- Epithelial-Mesenchymal Transition
- Fc Receptors
- Transcription
- Protein Microarrays
- High-Throughput Analysis
- Glycosylation
- Translation
- RNA-Binding Proteins
- Alternative Splicing
- Gene Regulation
- Cancer
- Innate Immunity
- Chromatin
- Ribosome
- Neurological Disorders
- ADAR Deaminases
- Histone Modifications
- RNA Editing
- Monoclonal Antibodies
- Therapeutic Antibodies
- TGF-ß
- Genomic Stability
- RNA-Guided
- Antisense Oligonucleotides
- Gene Therapy
- Predictive Modeling
- DNA Structure
- Idiopathic Pulmonary Fibrosis
- Social Policy
- Quantitative Analysis
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer5▲ 5.2×9 topics
- Gene Regulation4▲ 70×3 topics
- Innate Immunity4▲ 17×6 topics
- Alternative Splicing4▲ 107×1 topic
- Chromatin4▲ 109×2 topics
- RNA-Binding Proteins4▲ 107×1 topic
- Ribosome3▲ 91×1 topic
- Translation3▲ 28×1 topic
- Neurological Disorders3▲ 7.1×4 topics
- Glycosylation2▲ 33×3 topics
- ADAR Deaminases2▲ 146×1 topic
- High-Throughput Analysis2▲ 91×1 topic
- Histone Modifications2▲ 131×1 topic
- Protein Microarrays2▲ 185×1 topic
- RNA Editing2▲ 146×1 topic
- Transcription2▲ 131×1 topic
- Monoclonal Antibodies2▲ 36×2 topics
- Fc Receptors2▲ 54×1 topic
- Therapeutic Antibodies2▲ 43×1 topic
- Epithelial-Mesenchymal Transition2▲ 29×2 topics
- TGF-ß2▲ 17×2 topics
- Genome Engineering2▲ 41×1 topic
- Genomic Stability2▲ 68×2 topics
- Precision Medicine2▲ 5.1×4 topics
- RNA-Guided2▲ 41×1 topic
- Genomic Instability2▲ 22×2 topics
- Antisense Oligonucleotides2▲ 54×2 topics
- Fibrosis2▲ 11×2 topics
- Gene Therapy2▲ 12×2 topics
- Interstitial Lung Disease2▲ 35×2 topics
- Predictive Modeling2▲ 8.0×2 topics
- Therapeutic Targets2▲ 15×2 topics
- DNA Structure1▲ 108×1 topic
- G-Quadruplexes1▲ 108×1 topic
- Idiopathic Pulmonary Fibrosis1▲ 46×1 topic
- Myofibroblast1▲ 46×1 topic
- Social Policy1▲ 23×3 topics
- DNA Damage1▲ 24×1 topic
- Quantitative Analysis1▲ 9.5×2 topics
- Repair1▲ 84×1 topic
Which research topics does ProterixBio (United States) publish most on?
By volume in 2022-now: RNA Research and Splicing, RNA and protein synthesis mechanisms, RNA regulation and disease and Genomics and Chromatin Dynamics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 RNA Research and Splicing Molecular Biology 4 works
- 2 RNA and protein synthesis mechanisms Molecular Biology 3 works
- 3 RNA regulation and disease Molecular Biology 2 works
- 4 Genomics and Chromatin Dynamics Molecular Biology 2 works
- 5 Advanced Biosensing Techniques and Applications Molecular Biology 2 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 7 CRISPR and Genetic Engineering Molecular Biology 2 works
- 8 DNA and Nucleic Acid Chemistry Molecular Biology 1 works
- 9 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has ProterixBio (United States)'s research output changed?
Output in 2022-2025 was 4% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is ProterixBio (United States) as a percentage of every work published that year, 0.00030% in 2024.
Fractional works of ProterixBio (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Billerica
- Bruker (United States)
- Resonance Research (United States)
- Aerodyne Research
- Photonic Systems (United States)
- AST Products (United States)
- Entegris (United States)
- ClearMotion (United States)
- Superconducting Systems (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about ProterixBio (United States). Posts are plain text and can be reported.
